Intellectual Property
Jul. 21, 2015
Illumina defeats Columbia University gene patents
Illumina Inc. successfully struck down three gene sequencing patents held by Columbia University after the U.S. Court of Appeals for the Federal Circuit on Friday upheld previous rulings by the U.S. Patent and Trademark Office.
Daily Journal Staff Writer
Genetic sequencing technology developer Illumina Inc. successfully struck down three
gene sequencing patents held by Columbia University after the U.S. Court of Appeals
for the Federal Circuit upheld previous rulings by the U.S. Patent and Trademark Office.
<p/>
A three judge panel affirmed Friday that the university's claimed ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In